Drug Trial Radar · NCT02766608
Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD
Last checked: Nov 19, 2026Latest source record: Sep 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,389
Actual
Start
May 31, 2016
Primary completion
Dec 1, 2017
Study completion Dec 1, 2017
Sponsor
- Lead sponsor
- Pearl Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 10, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III randomized, double-blind, parallel group, multi-center, 24-week lung function study with BFF MDI (320/9.6 μg and 160/9.6 μg) compared to FF MDI 9.6 μg, BD MDI 320 μg, and open-label Symbicort® TBH (200/6 μg) administered BID.
Conditions
- Chronic Obstructive Pulmonary Disorder
Interventions
BFF MDI 320/9.6 μgDrug
Blinded Treatment
BFF MDI 160/9.6 μgDrug
Blinded Treatment
FF MDI 9.6 μgDrug
Blinded Treatment
BD MDI 320 μgDrug
Blinded Treatment
Symbicort® TBH 400/12 μg BIDDrug
Open Label
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Morning Pre-dose Trough FEV1 at Week 24 (BFF MDI Versus FF MDI)Time frame: at Week 24
- Change From Baseline in FEV1 AUC0-4 (BFF MDI vs BD MDI)Time frame: at Week 24
Locations
259 sites in 8 countries. Site status is shown where the registry gives one.
Research Site
Athens, Alabama
Research Site
Birmingham, Alabama
Research Site
Dothan, Alabama
Research Site
Phoenix, Arizona
Research Site
Phoenix, Arizona
Research Site
Tucson, Arizona
Research Site
Anaheim, California
Research Site
Gold River, California
Research Site
Palm Springs, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
Boulder, Colorado
Research Site
Colorado Springs, Colorado
Research Site
Littleton, Colorado
Research Site
Hamden, Connecticut
Research Site
Clearwater, Florida
Research Site
Clearwater, Florida
Research Site
DeLand, Florida
Research Site
Hialeah, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Panama City, Florida
Research Site
Port Orange, Florida
Research Site
Port Orange, Florida
Research Site
Tampa, Florida
Research Site
Winter Park, Florida
Research Site
Blue Ridge, Georgia
Research Site
Meridian, Idaho
Research Site
Towson, Maryland
Research Site
Westminster, Maryland
Research Site
North Dartmouth, Massachusetts
Research Site
Farmington Hills, Michigan
Research Site
Edina, Minnesota
Research Site
Fridley, Minnesota
Research Site
Minneapolis, Minnesota
Research Site
Woodbury, Minnesota
Research Site
Saint Charles, Missouri
Research Site
St Louis, Missouri
Research Site
Henderson, Nevada
Showing 40 of 259 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.